64

Bioinformatics of the Brain

[44] F. J. Rodriguez-Jimenez, J. Ureña-Peralta, P. Jendelova, et

al.,

“Alzheimer’s disease and synapse loss: What can we learn from induced

pluripotent stem cells? hipscs and alzheimer’s disease modeling,” Jour-

nal of Advanced Research, vol. 54, 2023.

[45] H. E. Marei, M. U. A. Khan, and A. Hasan, “Potential use of ipscs for

disease modeling, drug screening, and cell-based therapy for alzheimer’s

disease,” Cellular and Molecular Biology Letters, vol. 28, p. 98, 11 2023.

[46] K. H. Chang, G. J. Lee-Chen, C. C. Huang, et al., “Modeling alzheimer’s

disease by induced pluripotent stem cells carrying app d678h mutation,”

Molecular Neurobiology, vol. 56, 2019.

[47] S. Moore, L. D. Evans, T. Andersson, et al., “App metabolism regulates

tau proteostasis in human cerebral cortex neurons,” Cell Reports, vol. 11,

pp. 689–696, 5 2015.

[48] T. Kondo, Y. Yada, T. Ikeuchi, et al., “Cdip technology for reverse en-

gineering of sporadic alzheimer’s disease,” Journal of Human Genetics,

vol. 68, pp. 231–235, 3 2023.

[49] T. Kondo, N. Hara, S. Koyama, et al., “Dissection of the polygenic

architecture of neuronal aβ production using a large sample of individ-

ual ipsc lines derived from alzheimer’s disease patients,” Nature Aging,

vol. 2, pp. 125–139, 2 2022.

[50] S. Ghatak, N. Dolatabadi, D. Trudler, et al., “Mechanisms of hyper-

excitability in alzheimer’s disease hipsc-derived neurons and cerebral

organoids vs isogenic controls,” eLife, vol. 8, 11 2019.

[51] J. N. Rauch, G. Luna, E. Guzman, et al., “Lrp1 is a master regulator

of tau uptake and spread,” Nature, vol. 580, pp. 381–385, 4 2020.

[52] E. M. Abud, R. N. Ramirez, E. S. Martinez, et al., “ipsc-derived hu-

man microglia-like cells to study neurological diseases,” Neuron, vol. 94,

pp. 278–293.e9, 4 2017.

[53] B. J. Andreone, L. Przybyla, C. Llapashtica, et al., “Alzheimer’s-

associated plcγ2 is a signaling node required for both trem2 function and

the inflammatory response in human microglia,” Nature Neuroscience,

vol. 23, pp. 927–938, 8 2020.

[54] N. Fattorelli, A. Martinez-Muriana, L. Wolfs, et al., “Stem-cell-derived

human microglia transplanted into mouse brain to study human dis-

ease,” Nature Protocols, vol. 16, pp. 1013–1033, 2 2021.

[55] J. Hasselmann, M. A. Coburn, W. England, et al., “Development of

a chimeric model to study and manipulate human microglia in vivo,”

Neuron, vol. 103, pp. 1016–1033.e10, 9 2019.